Loading...
Docoh

Glaxosmithkline (GSK)

Institutional ownership

Data for period
(Last complete reporting period)
Institutional shares
Float
Outstanding shares
Total positions
Opened positions
Closed positions
Increased positions
Decreased positions

Latest institutional filings

Type Filer #Shares Filed For date #Previous %Chg Prev. Date
13F-HR
Advisors Asset Management 118.65K 17 May 22 31 Mar 22 100.34K +18% 31 Dec 21
13F-HR
Jane Street 653.35K 17 May 22 31 Mar 22 47.46K +1K% 31 Dec 21
13F-HR
BNP Paribas Arbitrage 4M 16 May 22 31 Mar 22 3.87M +3% 31 Dec 21
13F-HR
Lido Advisors 12.02K 16 May 22 31 Mar 22 12.54K -4% 31 Dec 21
13F-HR
MidWestOne Financial 5.2K 16 May 22 31 Mar 22 5.2K 0% 31 Dec 21
13F-HR
IHT Wealth Management 12.25K 16 May 22 31 Mar 22 10.75K +14% 31 Dec 21
13F-HR
FineMark National Bank & Trust 6.04K 16 May 22 31 Mar 22 6.04K 0% 31 Dec 21
13F-HR
Brookfield Asset Management 306.51K 16 May 22 31 Mar 22 0 +∞% 31 Dec 20
13F-HR
Cribstone Capital Management 140 16 May 22 31 Mar 22 152 -8% 31 Dec 21
13F-HR
Geneos Wealth Management 27.23K 16 May 22 31 Mar 22 27.49K -1% 31 Dec 21

About this data

This data is updated daily from 13F, 13D and 13G SEC filings.

Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.

GSK 5-year stock price

Institutional ownership trends

Institutional shares (*long positions only)
Institutional ownership (% of outstanding shares)
Number of holders
Opened vs closed positions (#holders, opened on top)
Increased vs decreased positions (#holders, increased on top)
Puts vs calls (#shares, puts on top)

Institutional ownership history data

All data in millions (MM) except percentages. "0.0" is < 100,000 and "0.0%" is < 0.1%
Filter holdings
Data to display
Shade data
Download data